EICHORCondition: Atopic Dermatitis · Sponsor: Amgen
The coprimary objectives of the study are to: * evaluate the efficacy of rocatinlimab in combination with topical corticosteroid and/or topical calcineurin inhibitor (TCS/TCI), compared with placebo in combination with TCS/TCI at Week 24, assessed using Validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD™). * evaluate the efficacy of rocatinlimab, in combination with TCS/TCI, compared with placebo in combination with TCS/TCI at Week 24, assessed using Eczema Area and Severity Index (EASI).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| The University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Medical Dermatology Specialists | Phoenix, Arizona, United States | — |
| Southwest Skin Specialists | Phoenix, Arizona, United States | — |
| US Dermatology Partners Sun City West | Sun City West, Arizona, United States | — |
| Arkansas Research Trials, LLC | North Little Rock, Arkansas, United States | — |
| Kern Research Inc | Bakersfield, California, United States | — |
| Keck Medicine of University of Southern California | Los Angeles, California, United States | — |
| Wallace Medical Group Inc | Los Angeles, California, United States | — |
| Antelope Valley Clinical Trials | Palmdale, California, United States | — |
| University of California at Davis Medical Center | Sacramento, California, United States | — |
| Kaiser Permanente South Sacramento Medical Center | Sacramento, California, United States | — |
| Acclaim Clinical Research | San Diego, California, United States | — |
+ 222 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05724199